A Future Perspective on Waste Management of Lithium-Ion Batteries for Electric Vehicles in Lao PDR: Current Status and Challenges

Lithium-ion batteries (LIBs) have become a hot topic worldwide because they are not only the best alternative for energy storage systems but also have the potential for developing electric vehicles (EVs) that support greenhouse gas (GHG) emissions reduction and pollution prevention in the transport sector. However, the recent increase in EVs has brought about a rise in demand for LIBs, resulting in a substantial number of used LIBs. The end-of-life (EoL) of batteries is related to issues including, for example, direct disposal of toxic pollutants into the air, water, and soil, which threatens organisms in nature and human health. Currently, there is various research on spent LIB recycling and disposal, but there are no international or united standards for LIB waste management. Most countries have used a single or combination methodology of practices; for instance, pyrometallurgy, hydrometallurgy, direct recycling, full or partial combined recycling, and lastly, landfilling for unnecessary waste. However, EoL LIB recycling is not always easy for developing countries due to multiple limitations, which have been problems and challenges from the beginning and may reach into the future. Laos is one such country that might face those challenges and issues in the future due to the increasing trend of EVs. Therefore, this paper intends to provide a future perspective on EoL LIB management from EVs in Laos PDR, and to point out the best approaches for management mechanisms and sustainability without affecting the environment and human health. Significantly, this review compares the current EV LIB management between Laos, neighboring countries, and some developed countries, thereby suggesting appropriate solutions for the future sustainability of spent LIB management in the nation. The Laos government and domestic stakeholders should focus urgently on specific policies and regulations by including the extended producer responsibility (EPR) scheme in enforcement

Landfill Biogas Recovery and Its Contribution to Greenhouse Gas Mitigation

This study assesses the biomethane (CH4) generation and greenhouse gas (GHG) emissions resulting from municipal solid waste landfilling in Phnom Penh, Cambodia, with a focus on the impact of fugitive CH4 emissions and operation processes in four landfilling scenarios: simple dumping (S1), improved management with leachate treatment (S2), engineered landfill with flaring (S3), and engineered landfill with energy recovery (S4). The study also considered the environmental benefits of carbon sequestration and landfill gas utilization. The LandGEM and IPCC FOD models were used to calculate CH4 generation over the period of 2009–2022, and it was found that approximately 18 and 21 M kg/year of CH4 were released, respectively. The energy potential from CH4 recovery was 51–61 GWh/year. Overall, GHG emissions in S2 were the highest, amounting to 409–509 M kg CO2-eq/year, while S1 had lower emissions at 397–496 M kg CO2-eq/year. Flaring-captured CH4 in S3 could reduce GHG emissions by at least 55%, and using captured CH4 for electricity production in S4 could mitigate at least 83% of GHG emissions. Electricity recovery (S4) could avoid significant amounts of GHG emissions (−52 to −63 kg CO2-eq/tMSW). The study suggests that landfill gas-to-energy could significantly reduce GHG emissions

Changing trends in the incidence (1999-2011) and mortality (1983-2013) of cervical cancer in the Republic of Korea

Cervical cancer is a well-known preventable cancer worldwide. Many countries including Korea have pursued the positive endpoint of a reduction in mortality from cervical cancer. Our aim is to examine changing trends in cervical cancer incidence and mortality after the implementation of a national preventive effort in Korea. Cervical cancer incidence data from 1999 to 2011 and mortality data from 1983 to 2013 were collected from the Korean Statistical Information Service. Yearly age-standardized rates (ASR) per 100,000 were compared using two standards: the 2005 Korean population and the world standard population, based on Segi’s world standard for incidence and the World Health Organization for mortality. In Korea, the age-standardized incidence of cervical cancer per 100,000 persons declined from 17.2 in 2000 to 11.8 in 2011. However, the group aged 25 to 29 showed a higher rate in 2011 (ASR, 6.5) than in 2000 (ASR, 3.6). The age-standardized mortality rate per 100,000 persons dropped from 2.81 in 2000 to 1.95 in 2013. In the worldwide comparison, the incidence rates remained close to the average incidence estimate of more developed regions (ASR, 9.9). The decreasing mortality trend in Korea approached the lower rate observed in Australia (ASR, 1.4) in 2010. Although the incidence rate of cervical cancer is continuously declining in Korea, it is still high relative to other countries. Moreover, incidence and mortality rates in females aged 30 years or under have recently increased. It is necessary to develop effective policy to reduce both incidence and mortality, particularly in younger age groups

Feasibility of monitoring Global Breast Cancer Initiative Framework key performance indicators in 21 Asian National Cancer Centers Alliance member countries

BackgroundThe Global Breast Cancer Initiative (GBCI) Framework, launched by the World Health Organisation (WHO) in 2023, emphasises assessing, strengthening, and scaling up services for the early detection and management of breast cancer. This study aims to determine the feasibility of monitoring the status of breast cancer control in the 21 Asian National Cancer Centers Alliance (ANCCA) countries based on the three GBCI Framework key performance indicators (KPIs): stage at diagnosis, time to diagnosis, and treatment completion.MethodsWe reviewed published literature on breast cancer control among 21 ANCCA countries from May to July 2023 to establish data availability and compiled the latest descriptive statistics and sources of the indicators using a standardised data collection form. We performed bivariate Pearson's correlation analysis to measure the strength of correlation between stage at diagnosis, mortality and survival rates, and universal health coverage.FindingsOnly 12 (57%) ANCCA member countries published national cancer registry reports on breast cancer age-standardised incidence rate (ASIR) and age-standardised mortality rate (ASMR). Indonesia, Myanmar, and Nepal had provincial data and others relied on WHO's Global Cancer Observatory (GLOBOCAN) estimates. GLOBOCAN data differed from the reported national statistics by 5–10% in Bhutan, Indonesia, Iran, the Republic of Korea, Singapore, and Thailand and >10% in China, India, Malaysia, Mongolia, and Sri Lanka. The proportion of patients diagnosed in stages I and II strongly correlated with the five-year survival rate and with the universal health coverage (UHC) index. Three countries (14%) reported national data with >60% of invasive breast cancer patients diagnosed at stages I and II, and a five-year survival rate of >80%. Over 60% of the ANCCA countries had no published national data on breast cancer staging, the time interval from presentation to diagnosis, and diagnosis to treatment. Five (24%) countries reported data on treatment completion. The definition of delayed diagnosis and treatment completion varied across countries.InterpretationGBCI's Pillar 1 KPI correlates strongly with five-year survival rate and with the UHC index. Most ANCCA countries lacked national data on cancer staging, timely diagnosis, and treatment completion KPIs. While institutional-level data were available in some countries, they may not represent the nationwide status. Strengthening cancer surveillance is crucial for effective breast cancer control. The GBCI Framework indicators warrant more detailed definitions for standardised data collection. Surrogate indicators which are measurable and manageable in country-specific settings, could be considered for monitoring GBCI indicators. Ensuring UHC and addressing health inequalities are essential to early diagnosis and treatment of breast cancer